Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT02719574
Title	Open-label Study of FT-2102 With or Without Azacitidine or Cytarabine in Patients With AML or MDS With an IDH1 Mutation
Recruitment	Completed
Gender	both
Phase	Phase I
Variant Requirements	Yes
Sponsors	Forma Therapeutics, Inc.
Indications	myelodysplastic syndrome acute myeloid leukemia
Therapies	Cytarabine + Olutasidenib Olutasidenib Azacitidine + Olutasidenib
Age Groups:	adult
Covered Countries	USA \| ITA \| GBR \| FRA \| ESP \| DEU \| CAN \| AUS